Mike Weiand has spent almost 8 years with Pacific Biosciences within field applications support, enabling their customers and growing the technology. There he helps manage and assist customers in designing and conducting experiments to initiate and validate the use of the PacBio sequencing in their laboratories. Prior to PacBio, Weiand held research and development roles at Life Technologies and the Broad Institute of MIT and Harvard. While with Life Technologies, his focus was in R&D product development, assay formulation, and designing user workflows of the PGM and Proton systems. At the Broad Institute, he spent over 9 years in technology development and technology exploration, validating, scaling, and implementing next generation sequencing technologies in the high-throughput DNA sequencing platform.